Product Information
ARIPIPRAZOLE 1 MG/ML SOLUTION is a generic product labeled by VistaPharm, LLC, priced at $0.3312 per ML under NDC 66689073505. Its NADAC has been published 317 times since Sep 9, 2020.
FDA first approved this application on Dec 26, 2019. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/mL
Manufacturer
VistaPharm, LLCNDC
66689073505
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA212870FDA Approved
12/26/2019
TE Code
AA
On Market Since
6/19/2020
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 84.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3312 per ML |
|---|---|
| All-time high | $2.1078 (Sep 16, 2020) |
| All-time low | $0.3131 (Aug 19, 2026) |
| 52-week high | $0.5159 |
| 52-week low | $0.3131 |
| Median price | $0.7973 |
| Average price | $0.8605 |
| Largest weekly change | +55.1% (Mar 22, 2023) |
| Weeks tracked | 317 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
VistaPharm, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 1 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 1 MG/ML SOLUTION, manufactured by VistaPharm, LLC, is $0.3312 per ML (NDC 66689073505), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 1 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has declined 84.3%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 1 MG/ML SOLUTION?
Since Sep 9, 2020, the NADAC for ARIPIPRAZOLE 1 MG/ML SOLUTION has ranged from a low of $0.3131 (Aug 19, 2026) to a high of $2.1078 (Sep 16, 2020), with a median of $0.7973 per ML.
Are there cheaper alternatives to ARIPIPRAZOLE 1 MG/ML SOLUTION?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 1 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 1 MG/ML SOLUTION?
ARIPIPRAZOLE 1 MG/ML SOLUTION (NDC 66689073505) is labeled by VistaPharm, LLC, and CMS classifies it as a generic product.